M A Matthay
Overview
Explore the profile of M A Matthay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
236
Citations
10946
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Pauluhn J, Carson A, Costa D, Gordon T, Kodavanti U, Last J, et al.
Inhal Toxicol
. 2007 Aug;
19(10):789-810.
PMID: 17687713
A workshop was held February 14, 2007, in Arlington, VA, under the auspices of the Phosgene Panel of the American Chemistry Council. The objective of this workshop was to convene...
22.
Godzich M, Hodnett M, Frank J, Su G, Pespeni M, Angel A, et al.
FASEB J
. 2006 Jun;
20(9):1519-21.
PMID: 16793871
Lung endothelial damage is a characteristic morphological feature of ischemia-reperfusion (I/R) injury, although the molecular steps involved in the loss of endothelial integrity are still poorly understood. We tested the...
23.
Ware L, Kaner R, Crystal R, Schane R, Trivedi N, McAuley D, et al.
Eur Respir J
. 2005 Jul;
26(1):101-5.
PMID: 15994395
Although overexpression of vascular endothelial growth factor (VEGF) 165 in the lung causes pulmonary oedema, its role in human acute lung injury (ALI) is unclear. VEGF levels are reported to...
24.
Lee H, Pespeni M, Roux J, Dennery P, Matthay M, Pittet J
FASEB J
. 2004 Nov;
19(2):287-9.
PMID: 15550551
Inhibition of cAMP-dependent stimulation of the vectorial fluid transport across the lung epithelium following hemorrhagic shock is mediated by NO released within the airspaces of the lung. We tested here...
25.
Garrity-Ryan L, Shafikhani S, Balachandran P, Nguyen L, Oza J, Jakobsen T, et al.
Infect Immun
. 2003 Dec;
72(1):546-58.
PMID: 14688136
ExoT is a type III secreted effector protein found in almost all strains of Pseudomonas aeruginosa and is required for full virulence in an animal model of acute pneumonia. It...
26.
Eisner M, Parsons P, Matthay M, Ware L, Greene K
Thorax
. 2003 Oct;
58(11):983-8.
PMID: 14586055
Background: Because injury to the alveolar epithelial barrier is a characteristic feature of acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS), plasma surfactant protein levels may have...
27.
Jasmer R, Matthay M
J Clin Monit Comput
. 2003 Feb;
16(5-6):403-8.
PMID: 12580223
Noninvasive ventilation refers to any form of ventilatory support applied without the use of an endotracheal tube. It offers the potential to provide primary treatment for acute respiratory failure while...
28.
Sartori C, Matthay M
Eur Respir J
. 2002 Nov;
20(5):1299-313.
PMID: 12449188
Pulmonary oedema is a life-threatening condition that frequently leads to acute respiratory failure. From a physiological perspective, pulmonary oedema develops either because of an increase in lung vascular hydrostatic pressure...
29.
Sartori C, Fang X, McGraw D, Koch P, Snider M, Folkesson H, et al.
J Appl Physiol (1985)
. 2002 Oct;
93(5):1875-80.
PMID: 12381778
Stimulation of active fluid transport with beta-adrenergic receptor (betaAR) agonists can accelerate the resolution of alveolar edema. However, chronic betaAR-agonist administration may cause betaAR desensitization and downregulation that may impair...
30.
Atabai K, Matthay M
Thorax
. 2002 Apr;
57(5):452-8.
PMID: 11978926
An understanding of the epidemiology of ALI/ARDS and the effects of treatment have been hampered by the lack of a uniform definition of the syndrome. Various definitions have been proposed,...